Cambridge Investment Research Advisors’s Unilife Corporation UNIS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-4,320
Closed -$29K 1721
2016
Q1
$29K Hold
4,320
﹤0.01% 1577
2015
Q4
$21K Buy
+4,320
New +$34K ﹤0.01% 1555
2015
Q3
Sell
-2,920
Closed -$63K 1641
2015
Q2
$63K Buy
2,920
+600
+26% +$18.2K ﹤0.01% 1399
2015
Q1
$93K Buy
2,320
+171
+8% +$6.84K ﹤0.01% 1344
2014
Q4
$72K Buy
2,149
+250
+13% +$7.93K ﹤0.01% 1313
2014
Q3
$44K Sell
1,899
-450
-19% -$11.4K ﹤0.01% 1429
2014
Q2
$70K Buy
2,349
+250
+12% +$7.83K ﹤0.01% 1300
2014
Q1
$85K Buy
2,099
+550
+36% +$24.8K ﹤0.01% 1246
2013
Q4
$68K Buy
+1,549
New +$56.7K ﹤0.01% 1199
2013
Q3
Sell
-1,079
Closed -$34K 1247
2013
Q2
$34K Buy
+1,079
New +$29.8K ﹤0.01% 1090

Other funds holding UNIS

Cambridge Investment Research Advisors's UNIS Position: Q2 2016 in Review

Cambridge Investment Research Advisors sold out of Unilife Corporation (UNIS) in Q2 2016, closing a stake of 4,320 shares — an estimated $29K sold.

Cambridge Investment Research Advisors first reported a position in UNIS in Q2 2013 and held it in 10 quarters. The position peaked at $93K in Q1 2015. 41 funds tracked by Wall St. Rank hold UNIS as of Q2 2016.

  • Cambridge Investment Research Advisors reported no remaining Unilife Corporation position as of Q2 2016 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 4,320 Unilife Corporation shares in Q2 2016, an estimated $29K.
  • Cambridge Investment Research Advisors first reported a position in Unilife Corporation in Q2 2013 and held it in 10 quarters.
  • Cambridge Investment Research Advisors's Unilife Corporation position peaked at $93K in Q1 2015.
  • 41 funds tracked by Wall St. Rank held Unilife Corporation as of Q2 2016.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2016, filed 4 Aug 2016.